Emcure Pharmaceuticals Ltd. IPO

Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical company known for its research and development. They offer a wide range of medications across various therapeutic areas, including gynecology and HIV/AIDS antivirals where they hold the top spot in India. They are rapidly growing with a strong presence in over 70 countries, particularly India, Europe, and Canada. Their focus on chronic illnesses positions them well for future growth in the Indian market.

RHP
View
DRHP
View
Open Date

2024-07-03

Close Date

2024-07-05

Emcure Pharmaceuticals Ltd. IPO Details

Check out the issue details for Emcure Pharmaceuticals Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1008

Price Band

₹ 960 - 1008

Issue Size

1952.03 Cr.

Issue Type

Book Built

Open

2024-07-03

Close

2024-07-05

Listingprice

₹ 1325.05

ListingGain

31.45%

Listing Date

2024-07-10

CMP

₹ 1408.5

Current Return

39.73%

Company Financials

You can get the following financial statements of Emcure Pharmaceuticals Ltd. as of now.

The details about the Emcure Pharmaceuticals Limited IPO is as:

  • The issue size of the Emcure Pharmaceuticals Limited IPO is 1952.03 Cr.
  • The price band for Emcure Pharmaceuticals Limited IPO is Rs 960 to Rs 1008.
  • The shares of Emcure Pharmaceuticals Limited IPO will list on 10th July 2024.
  • The latest tentative GMP of Emcure Pharmaceuticals Limited IPO is Rs 295.
  • The shares of Emcure Pharmaceuticals Limited IPO is subscribed 67.85 Times as of 5th July 2024. 

 

Emcure Pharmaceuticals Limited IPO Valuation

The approx valuation of Emcure Pharmaceuticals Limited IPO based on its price band and DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 1008
Existing Shares (Qty) 18.11 Cr
Fresh Issue 800 Cr
Market Cap 19,054.88 Cr
EPS (FY24) Rs 27.54
PE Ratio 36.60x
Industry PE 40.41x

 

Emcure Pharmaceuticals Limited IPO Issue Size

Emcure Pharmaceuticals Limited IPO issue size is 1952.03 Cr

Issue Amount
Fresh Issue 800 Cr
Offer For Sale 1152.03 Cr

 

Emcure Pharmaceuticals Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 14 shares and a maximum of 14 lots of 196 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 14 14,112
 Maximum 14 196 1,97,568

 

Emcure Pharmaceuticals Limited IPO share offer

The shares of Emcure Pharmaceuticals Limited IPO is subscribed 67.85 Times as of 5th July 2024. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 191.24 Times
Non-Institutional Minimum 15% 49.29 Times
Retail Individual Minimum 35% 7.34 Times
Employee 1,08,900 Shares 8.80 Times
Total   67.85 Times

Find below the dates for Emcure Pharmaceuticals Limited IPO:

Schedule Date
Basis of Allotment 8 July 2024
Refunds 9 July 2024
Credit to Demat Account 9 July 2024
IPO Listing Date 10 July 2024

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 3153.66 3387.24 3107.09 3497.66 4381.92
Total Expenditure 2410.26 2592.57 2668.59 3055.76 3758.76
Operating Profit 743.41 794.67 438.49 441.89 623.17
Other Income 111.91 132.68 125.35 138.26 142.48
Interest 123.34 145.14 166.83 166.09 112.96
Depreciation 156.24 165.79 178.52 204.83 224.97
Exceptional Items -18.29 0 -6.15 -9.32 0
Profit Before Tax 557.45 616.42 212.34 199.91 427.71
Provision for Tax 136.97 169.61 52.28 39.08 110.58
Net Profit 420.48 446.81 160.06 160.83 317.13
Adjusted EPS (Rs.) 2.32 2.47 0.89 0.89 1.67

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 180.85 180.85 180.85 181.15 189.48
Total Reserves 2120.92 1531.68 1661.02 1753.95 2834.88
Borrowings 645.97 512.4 600.65 438.21 406.29
Other N/C liabilities 126.27 164.19 177 253.51 266.3
Current liabilities 1789.18 1934.06 1996.33 2130.12 1719.16
Total Liabilities 4863.2 4323.18 4615.85 4756.93 5416.11
Assets
Net Block 1277.9 1307.36 1432.71 1718.24 1759.06
Capital WIP 192.09 239.25 253.1 106.4 92.83
Intangible WIP 0 0 0 0 6.28
Investments 863.73 563.36 690.02 684 677.65
Loans & Advances 299.42 63.25 77.51 105.37 393.13
Other N/C Assets 27.38 13.92 23.01 24.91 27.11
Current Assets 2202.68 2136.05 2139.51 2118.01 2460.05
Total Assets 4863.2 4323.18 4615.85 4756.93 5416.11
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Other Income 27.94 54.93 19.41 22.4 21.52
Profit Before Tax 55.05 119.36 67.25 186.05 165.67
Tax 14.6 32.44 17.05 46.5 42.88
Profit After Tax 40.45 86.92 50.2 139.56 122.79
Adjusted EPS (Rs) 2.23 4.6 2.65 7.37 6.48

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 77.91 0.04
Mar 2025 77.92 0.04
Dec 2024 77.94 0
Sep 2024 78.08 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 557.45 616.42 212.34 199.91 427.71
Adjustment 246.72 265 309.21 325.56 284.14
Changes in Assets & Liabilities 84.38 -283.04 68.37 126.36 -87.45
Tax Paid -113.67 -170.67 -84.54 -66.86 -66.11
Operating Cash Flow 774.87 427.71 505.37 584.97 558.29
Investing Cash Flow -835.78 -393.81 -270.56 -173.08 -437.66
Financing Cash Flow 30.97 -342.96 -54.52 -287.75 -49.25
Net Cash Flow -29.94 -309.06 180.3 124.15 71.38
X